Gregory Evans to Randomized Controlled Trials as Topic
This is a "connection" page, showing publications Gregory Evans has written about Randomized Controlled Trials as Topic.
Connection Strength
0.242
-
Pop-Busui R, Evans GW, Gerstein HC, Fonseca V, Fleg JL, Hoogwerf BJ, Genuth S, Grimm RH, Corson MA, Prineas R. Effects of cardiac autonomic dysfunction on mortality risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Diabetes Care. 2010 Jul; 33(7):1578-84.
Score: 0.066
-
Bots ML, Evans GW, Riley W, Meijer R, McBride KH, Paskett ED, Helmond FA, Grobbee DE. The Osteoporosis Prevention and Arterial effects of tiboLone (OPAL) study: design and baseline characteristics. Control Clin Trials. 2003 Dec; 24(6):752-75.
Score: 0.043
-
Bots ML, Evans GW, Tegeler CH, Meijer R. Carotid Intima-media Thickness Measurements: Relations with Atherosclerosis, Risk of Cardiovascular Disease and Application in Randomized Controlled Trials. Chin Med J (Engl). 2016 Jan 20; 129(2):215-26.
Score: 0.025
-
Getaneh A, Light LS, Brillon DJ, Calles Escandón J, Felicetta J, Evans GW, Lopez-Jimenez CR, Cuddihy R, Bigger JT. Diabetes control among Hispanics in the action to control cardiovascular risk in diabetes trial. J Gen Intern Med. 2012 Nov; 27(11):1499-505.
Score: 0.019
-
Peters SA, den Ruijter HM, Palmer MK, Grobbee DE, Crouse JR, O'Leary DH, Evans GW, Raichlen JS, Bots ML. Biologically implausible carotid intima-media thickness measurement values: effects on rate of change over time. Curr Med Res Opin. 2012 Jun; 28(6):891-9.
Score: 0.019
-
Peters SA, Palmer MK, den Ruijter HM, Grobbee DE, Crouse JR, O'Leary DH, Evans GW, Raichlen JS, Bots ML. Sample size requirements in trials using repeated measurements and the impact of trial design. Curr Med Res Opin. 2012 May; 28(5):681-8.
Score: 0.019
-
Dogan S, Duivenvoorden R, Grobbee DE, Kastelein JJ, Shear CL, Evans GW, Visseren FL, Bots ML. Ultrasound protocols to measure carotid intima-media thickness in trials; comparison of reproducibility, rate of progression, and effect of intervention in subjects with familial hypercholesterolemia and subjects with mixed dyslipidemia. Ann Med. 2010 Sep; 42(6):447-64.
Score: 0.017
-
Cushman WC, Grimm RH, Cutler JA, Evans GW, Capes S, Corson MA, Sadler LS, Alderman MH, Peterson K, Bertoni A, Basile JN. Rationale and design for the blood pressure intervention of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Am J Cardiol. 2007 Jun 18; 99(12A):44i-55i.
Score: 0.013
-
Bots ML, Evans GW, Riley WA, Grobbee DE. Carotid intima-media thickness measurements in intervention studies: design options, progression rates, and sample size considerations: a point of view. Stroke. 2003 Dec; 34(12):2985-94.
Score: 0.011
-
Mancini GB, Miller ME, Evans GW, Byington R, Furberg CD, Pitt B. Post hoc analysis of coronary findings from the prospective randomized evaluation of the vascular effects of the Norvasc trial (PREVENT). Am J Cardiol. 2002 Jun 15; 89(12):1414-6.
Score: 0.010